XML 12 R2.htm IDEA: XBRL DOCUMENT v3.24.3
Condensed Consolidated Balance Sheets - USD ($)
Sep. 30, 2024
Mar. 31, 2024
Current Assets    
Cash and cash equivalents $ 428,475 $ 329,860
Prepaid expenses and other assets 17,564 9,075
Total Current Assets 446,039 338,935
Current Liabilities    
Accounts payable 447,688 447,862
Accrued expenses 465,533 433,201
Stock repurchase payable 400,000 400,000
Total Current Liabilities 1,613,221 1,631,063
Long-Term Liabilities    
Accrued expenses 1,382,517 1,357,739
Total Long-Term Liabilities 4,672,575 4,647,797
Total Liabilities 6,285,796 6,278,860
Stockholders’ Deficit    
Preferred stock, authorized 10,000,000 shares, par value $0.001; -0- shares issued and outstanding
Common stock, authorized 500,000,000 shares, par value $0.001; 43,063,441 shares issued and outstanding as of September, 30 2024; and 42,258,441 shares issued and oustanding as of March, 31 2024 43,064 42,259
Additional paid-in capital 31,718,877 30,914,682
Accumulated deficit (37,601,698) (36,896,866)
Total Stockholders’ Deficit (5,839,757) (5,939,925)
Total Liabilities and Stockholders’ Deficit 446,039 338,935
Nonrelated Party [Member]    
Current Liabilities    
Current portion of notes payable, 300,000 300,000
Related Party [Member]    
Current Liabilities    
Current portion of notes payable, 50,000
Long-Term Liabilities    
Notes payable, net of current portion, net of debt discount $ 3,290,058 $ 3,290,058